Liver Immunity-Guided Discovery of Capsule-Permeable Protein Antigens Against Bacterial Sepsis

The capsules of invasive bacteria shield underlying antigens, limit immune clearance and hinder vaccine noncapsular antigen discovery. To address this, we developed Liver-based Vaccine Antigen Capture (L-VAC), a functional platform integrating antibody-mediated screening with in vivo visualization of hepatic bacterial clearance in mice. Applying L-VAC to Streptococcus pneumoniae identified multiple capsule-permeable proteins that induce rapid hepatic clearance of blood-borne bacteria. Immunization with these proteins, especially in a multivalent formulation, conferred broad cross-serotype protection. Spatial analyses revealed that only the proteins localized at or near the capsular surface are targetable for vaccine-induced pathogen capture in the liver sinusoids. These findings establish L-VAC as a sensitive and reliable approach for identifying protective protein antigens capable of overcoming capsule barriers, offering a promising strategy to develop broadly protective vaccines against multidrug-resistant encapsulated pathogens.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2026-11-13
DOI
https://doi.org/10.64898/2026.11.12.765860
Primary Topic
Bacterial Infections and Vaccines
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Liver Immunity-Guided Discovery of Capsule-Permeable Protein Antigens Against Bacterial Sepsis

Yanrong Wu, Jeremy Brown, HaiTeng DENG, Qian Jin et al.
bioRxiv (Cold Spring Harbor Laboratory)
Bacterial Infections and Vaccines
preprint

Liver Immunity-Guided Discovery of Capsule-Permeable Protein Antigens Against Bacterial Sepsis

Yanrong Wu, Jeremy Brown, HaiTeng DENG, Qian Jin, Jing-Ren Zhang, Juanjuan Wang, Wengweng Zeng
preprint en

Abstract

The capsules of invasive bacteria shield underlying antigens, limit immune clearance and hinder vaccine noncapsular antigen discovery. To address this, we developed Liver-based Vaccine Antigen Capture (L-VAC), a functional platform integrating antibody-mediated screening with in vivo visualization of hepatic bacterial clearance in mice. Applying L-VAC to Streptococcus pneumoniae identified multiple capsule-permeable proteins that induce rapid hepatic clearance of blood-borne bacteria. Immunization with these proteins, especially in a multivalent formulation, conferred broad cross-serotype protection. Spatial analyses revealed that only the proteins localized at or near the capsular surface are targetable for vaccine-induced pathogen capture in the liver sinusoids. These findings establish L-VAC as a sensitive and reliable approach for identifying protective protein antigens capable of overcoming capsule barriers, offering a promising strategy to develop broadly protective vaccines against multidrug-resistant encapsulated pathogens.

bioRxiv (Cold Spring Harbor Laboratory)
University College London (GB), China Agricultural University (CN), Tsinghua University (CN)
Bacterial Infections and Vaccines
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon